ArticleInternational journal of molecular sciences2026
CD271 Identifies a Subpopulation with Enhanced Neural-like Potential Within Wharton Jelly Derived Mesenchymal Stem/Stromal Cells.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The heterogenous mesenchymal stem/stromal cells (MSCs) express the surface antigens associated with distinct cell subpopulations. CD271, characteristic of stem cells derived from the neural crest, could indicate cells with a unique phenotype. The study examined whether the CD271+ subpopulation characterized by better stem and neural properties than the heterogeneous MSC population. The initial Wharton jelly-derived MSCs (WJ-MSCs) population was divided into two subpopulation: CD271-positive (WJ-MSC-CD271+) and CD271-negative (WJ-MSC-CD271-) with Fluorescence-Activated Cell Sorting (FACS). We compared the clonogenic potential and neural marker expression under standard culture conditions and in the presence of nerve tissue components-cerebrospinal fluid (CSF) or nerve tissue fragments (hippocampus). FACS allowed the enrichment of CD271+ cells from 1% to approximately 50%. WJ-MSC-CD271+ is characterized by significantly more self-renewal cells and increased expression of neuronal genes than WJ-MSC-CD271-. Under co-culture with CSF or hippocampal fragments, WJ-MSC-CD271+ contained more cells expressing Β-III-tubulin as well. Finally, we reported that stimulation with epithelial growth factor (EGF) and basal fibroblast growth factor (bFGF) enhanced CD271+ numbers in the initial population and stabilized them in further cell culture. WJ-MSC-CD271+ cells showed improved potential for differentiation into neural progenitors, although further research is needed for their potential use in neurological diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.